La financiación de las nuevas terapias
| dc.contributor.author | López i Casasnovas, Guillem | |
| dc.date.accessioned | 2022-11-23T10:27:49Z | |
| dc.date.available | 2022-11-23T10:27:49Z | |
| dc.date.issued | 2022-11 | |
| dc.format.mimetype | application/pdf | * |
| dc.identifier.uri | http://hdl.handle.net/10230/54982 | |
| dc.language.iso | spa | ca |
| dc.relation.ispartofseries | Health Policy Papers (CRES);16 (2022) | |
| dc.rights | This is an Open Access article distributed under the terms of the Creative Commons Attribution License Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properlyattributed. | ca |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | ca |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | ca |
| dc.subject.other | Medicina personalitzada | ca |
| dc.subject.other | Farmacogenètica | ca |
| dc.title | La financiación de las nuevas terapias | ca |
| dc.type | info:eu-repo/semantics/workingPaper | ca |
Fitxers
Paquet original
1 - 1 de 1
Carregant...
- Nom:
- WPHPP2022-16_GL.pdf
- Mida:
- 1.02 MB
- Format:
- Adobe Portable Document Format
- Descripció:
Col·leccions
Llicència
